arrow
K

Karl-Josef Langen

Helmholtz Association
H指数:72
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

O-(2-[18F]fluoroethyl)-L-tyrosine-PET-guided versus contrast-enhanced T1-weighted MRI-guided re-irradiation in patients with recurrent glioblastoma (GLIAA/NOA-10 ARO2013-01): a multicentre, open-label, randomised trial

O-(2-[18F]fluoroethyl)-L-tyrosine-PET引导与对比增强T1加权MRI引导的重复照射在复发性胶质母细胞瘤患者中的比较(GLIAA/NOA-10 ARO2013-01):一项多中心、开放标签、随机试验

2025-12-190
OAAI
Clinical potential of [18F]FET PET in patients with circumscribed astrocytic glioma

[18F]FET PET在局限性星形细胞胶质瘤患者中的临床潜力

2025-11-180
OAAI
IMG-76. FET PET reveals considerable volumetric and spatial differences in tumor burden compared to conventional MRI in recurrent glioblastoma

IMG-76. FET PET显示与常规MRI相比,在复发胶质母细胞瘤的肿瘤负荷方面存在显著的数量和空间差异。

2025-11-110
OA
PROGNOSTIC RELEVANCE OF PREOPERATIVE FET PET IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

术前氟乙基-18F-脱氧葡萄糖正电子发射断层扫描(FET PET)对 newly diagnosed glioblastoma 患者的预后价值

2025-11-010
OAAI
Metabolic response using the PET RANO 1.0 criteria following chemoradiation is associated with an increase in functional connectivity

使用PET RANO 1.0标准评估的化疗放疗后的代谢反应与功能连接的增加相关

2025-11-010
PRE
Assessment of18F-FET PET-based response to bevacizumab-based regimens in patients with glioblastoma at relapse using the PET RANO 1.0 criteria

基于18F-FET PET的贝伐珠单抗方案对复发胶质母细胞瘤患者疗效评估,采用PET RANO 1.0标准

2025-11-010
OAAI
GLIOBLASTOMA BEYOND THE ENHANCING TUMOR MARGINS: A LONGITUDINAL CASE STUDY COMPARING FET PET WITH MRI-BASED AI INFILTRATION MAPS

胶质母细胞瘤超出增强肿瘤边界:一项比较FET PET与基于MRI的AI浸润图的纵向病例研究

2025-11-010
OAAI
CLINICAL UTILITY OF [18F]FET PET IN PATIENTS WITH CIRCUMSCRIBED ASTROCYTIC GLIOMA

[18F]FET PET在局限性星形细胞胶质瘤患者中的临床应用价值

2025-10-010
OA
FULLY AUTOMATED EVALUATION OF FET PET IN BRAIN TUMOR PATIENTS - AN INTERNATIONAL, MULTICENTER STUDY

脑肿瘤患者FET PET的完全自动化评估——一项国际、多中心研究

2025-10-010
OAAI
Update to the RANO working group and EANO recommendations for the clinical use of PET imaging in gliomas

更新RANO工作组及EANO关于PET成像在胶质瘤临床应用的建议

2025-07-280
OAAI
Functional connectivity between tumor region and resting-state networks as imaging biomarker for overall survival in recurrent gliomas diagnosed by O-(2-[18F]fluoroethyl)-l-tyrosine PET
2025-01-290
OAAI
Borderline Findings in O-(2-[18F]-Fluoroethyl)-L-Tyrosine PET of Patients with Suspected Glioma Relapse: Role in Clinical Practice

O-(2-[18F]-Fluoroethyl)-L-Tyrosine PET在疑似胶质瘤复发的患者中边缘性发现:其在临床实践中的作用

2025-01-160
PRE